Instrumentation Metrics' Noninvasive Glucose Monitor Pivotal Study Planned
This article was originally published in The Gray Sheet
Executive SummaryInstrumentation Metrics will complete a clinical trial later in March for its IM200 noninvasive glucose monitor in anticipation of a 300 to 400-patient, multi-center pivotal study. The Chandler, Arizona firm plans to submit a premarket approval application for the device in late 2002 or early 2003.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.